BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 56 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,804 | -3.7% | 3,290 | 0.0% | 0.03% | +3.2% |
| Q2 2023 | $133,706 | -31.2% | 3,290 | -29.1% | 0.03% | -35.4% |
| Q1 2023 | $194,230 | -3.9% | 4,640 | 0.0% | 0.05% | -11.1% |
| Q4 2022 | $202,211 | +12.3% | 4,640 | 0.0% | 0.05% | 0.0% |
| Q3 2022 | $180,000 | -8.2% | 4,640 | 0.0% | 0.05% | -6.9% |
| Q2 2022 | $196,000 | -7.1% | 4,640 | 0.0% | 0.06% | +13.7% |
| Q1 2022 | $211,000 | -6.6% | 4,640 | -0.3% | 0.05% | -7.3% |
| Q4 2021 | $226,000 | -2.6% | 4,654 | -4.4% | 0.06% | -6.8% |
| Q3 2021 | $232,000 | -1.7% | 4,869 | 0.0% | 0.06% | -3.3% |
| Q2 2021 | $236,000 | +4.4% | 4,869 | -0.6% | 0.06% | -3.2% |
| Q1 2021 | $226,000 | -6.6% | 4,900 | 0.0% | 0.06% | -4.5% |
| Q4 2020 | $242,000 | – | 4,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE INVESTMENT CONSULTANTS HOLDING COMPANY, LLC | 18,736 | $675,000 | 0.94% |
| CORRADO ADVISORS, LLC | 9,565 | $344,000 | 0.32% |
| Rikoon Group, LLC | 19,188 | $692,000 | 0.29% |
| Eudaimonia Partners, LLC | 4,875 | $176,000 | 0.08% |
| Arete Wealth Advisors, LLC | 10,183 | $367,000 | 0.07% |
| CENTAURUS FINANCIAL, INC. | 8,465 | $305,000 | 0.06% |
| Cetera Advisors LLC | 17,379 | $627,000 | 0.03% |
| Jacobi Capital Management LLC | 4,034 | $145,000 | 0.03% |
| Financial Advantage, Inc. | 773 | $27,000 | 0.02% |
| MID ATLANTIC FINANCIAL MANAGEMENT INC/ADV | 5,868 | $212,000 | 0.02% |